Stories > Biotech Industry Faces Funding Challenges and IPO Dry Spell

Biotech Industry Faces Funding Challenges and IPO Dry Spell

Biotech Downturn and Funding Challenges

Biotech Funding Challenges and IPO Droug...

International Stocks Rise, Thermo Fisher...

AHF Criticizes Gilead Sciences for Profi...

AbbVie's Healthcare Acquisitions

Afya Limited Expands Medical Seats in Br...